October 21, 2022
Give to the GW COVID-19 Response Fund so we can provide lifesaving care to our community and protect our medical professionals during this pandemic.
GW School of Medicine and Health Sciences and the GW MFA Recruiting Participants for Final Stage of the NIAID’s COVAIL Trial
October 19, 2022
The GW School of Medicine and Health Sciences is recruiting participants for the final stage of a clinical trial to evaluate two Omicron-specific vaccines. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and Infectious…
GW Awarded Grant to Improve Cultural Responsiveness and Nonjudgmental Communication about HIV and COVID Screening
September 11, 2022
Researchers at the GW School of Medicine and Health Sciences received a pair of grants totaling more than $816,000 from Gilead Science, Inc., in support of an 18-month research informed educational initiative, Two in One: HIV+COVID Screening and Testing Model, to study pairing routinize HIV…
August 9, 2022
A research team led by Jonathan Silverberg, MD, PhD, MPH, professor of dermatology at the George Washington University School of Medicine and Health Sciences, has identified which acute symptom clusters may lead to long-term, chronic infection and which individuals are most likely to develop Long…
August 8, 2022
Following the completion of its grant from the D.C. Department of Health, the George Washington University (GW) Medical Faculty Associates (MFA) COVID-19 Vaccine Center (GW Vaccine Center) discontinued its vaccination operations on Aug. 5, 2022.
GW School of Medicine and Health Sciences and the GW MFA Serve as one of 24 participating trial sites for the NIAID’s COVAIL Trial
April 7, 2022
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to…
March 24, 2022
WASHINGTON (March 24, 2022) -
January 25, 2022
George Washington University researchers have developed a blood test that quickly detects if someone has COVID-19 and predicts how severely the immune system will react to the infection, according to a new study coming out today in PLOS One. The findings could one day lead to a powerful tool to…
January 12, 2022
Return to campus information for Jan. 18, 2022.
January 5, 2022
A $1 million gift from Ulvi M. and Reykhan Kasimov seeks to advance development of a new technique that uses RNA transcript levels to identify biomarkers in the blood stream, which can help detect active infections in the body.